Westpac Banking Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Sell
192,545
-9,170
-5% -$535K 0.81% 18
2025
Q4
$10.9M Buy
201,715
+46,386
+30% +$2.23M 0.69% 25
2025
Q3
$7.01M Sell
155,329
-2,553
-2% -$119K 0.43% 54
2025
Q2
$7.31M Sell
157,882
-821
-0.5% -$40.3K 0.49% 49
2025
Q1
$9.68M Buy
158,703
+115,530
+268% +$6.73M 0.71% 25
2024
Q4
$2.44M Buy
43,173
+4,840
+13% +$270K 0.16% 144
2024
Q3
$1.98M Buy
38,333
+15,633
+69% +$733K 0.13% 168
2024
Q2
$943K Sell
22,700
-98,680
-81% -$4.42M 0.07% 203
2024
Q1
$6.58M Buy
121,380
+11,250
+10% +$573K 0.5% 43
2023
Q4
$5.65M Sell
110,130
-5,041
-4% -$265K 0.47% 54
2023
Q3
$6.68M Buy
115,171
+236
+0.2% +$14.5K 0.5% 43
2023
Q2
$7.35M Sell
114,935
-318,663
-73% -$21.4M 0.52% 41
2023
Q1
$30.1M Buy
433,598
+8,293
+2% +$585K 0.4% 44
2022
Q4
$30.6M Buy
425,305
+31,806
+8% +$2.4M 0.45% 35
2022
Q3
$28M Buy
393,499
+15,379
+4% +$1.12M 0.43% 35
2022
Q2
$29.1M Buy
378,120
+127,325
+51% +$9.7M 0.38% 49
2022
Q1
$18.3M Buy
250,795
+54,004
+27% +$3.63M 0.21% 117
2021
Q4
$12.3M Buy
196,791
+17,359
+10% +$1.02M 0.13% 201
2021
Q3
$10.6M Sell
179,432
-12,605
-7% -$830K 0.11% 231
2021
Q2
$12.8M Sell
192,037
-22,188
-10% -$1.45M 0.13% 201
2021
Q1
$13.5M Buy
214,225
+12,195
+6% +$759K 0.15% 177
2020
Q4
$12.5M Sell
202,030
-49,466
-20% -$3.04M 0.14% 178
2020
Q3
$15.2M Sell
251,496
-24,380
-9% -$1.47M 0.21% 120
2020
Q2
$16.2M Sell
275,876
-42,816
-13% -$2.56M 0.24% 107
2020
Q1
$17.8M Sell
318,692
-62,830
-16% -$3.84M 0.31% 86
2019
Q4
$24.5M Buy
381,522
+81,219
+27% +$4.65M 0.32% 77
2019
Q3
$15.2M Sell
300,303
-65,806
-18% -$3.09M 0.21% 128
2019
Q2
$16.6M Buy
366,109
+10,684
+3% +$498K 0.25% 108
2019
Q1
$17M Sell
355,425
-45,548
-11% -$2.27M 0.28% 98
2018
Q4
$20.8M Buy
400,973
+61,963
+18% +$3.33M 0.36% 72
2018
Q3
$21M Buy
339,010
+86,587
+34% +$5.14M 0.36% 72
2018
Q2
$14M Buy
252,423
+6,468
+3% +$349K 0.27% 110
2018
Q1
$15.6M Buy
245,955
+61,680
+33% +$3.97M 0.31% 88
2017
Q4
$11.3M Sell
184,275
-26,000
-12% -$1.63M 0.26% 114
2017
Q3
$13.4M Sell
210,275
-3,401
-2% -$199K 0.3% 89
2017
Q2
$11.9M Sell
213,676
-14,493
-6% -$789K 0.26% 97
2017
Q1
$12.4M Buy
228,169
+16,366
+8% +$898K 0.1% 217
2016
Q4
$10.6M Buy
211,803
+110,347
+109% +$6.03M 0.1% 218
2016
Q3
$5.47M Sell
101,456
-51,645
-34% -$3.32M 0.06% 338
2016
Q2
$11.2M Sell
153,101
-14,675
-9% -$1.04M 0.12% 190
2016
Q1
$10.7M Buy
167,776
+56,941
+51% +$3.59M 0.12% 185
2015
Q4
$7.62M Sell
110,835
-3,569
-3% -$236K 0.08% 224
2015
Q3
$6.77M Buy
114,404
+62,053
+119% +$3.94M 0.07% 250
2015
Q2
$3.48M Sell
52,351
-54,213
-51% -$3.57M 0.03% 367
2015
Q1
$7.82M Sell
106,564
-32,603
-23% -$2.04M 0.07% 278
2014
Q4
$8.22M Sell
139,167
-117,595
-46% -$6.63M 0.08% 255
2014
Q3
$13.1M Buy
256,762
+103,427
+67% +$5.17M 0.13% 174
2014
Q2
$7.44M Buy
153,335
+34,628
+29% +$1.71M 0.07% 275
2014
Q1
$6.17M Buy
118,707
+10,298
+9% +$548K 0.07% 279
2013
Q4
$5.76M Buy
108,409
+102
+0.1% +$5.2K 0.07% 282
2013
Q3
$5.01M Sell
108,307
-154,632
-59% -$6.79M 0.06% 289
2013
Q2
$11.1M Buy
+262,939
New +$11.4M 0.17% 157

Other funds holding BMY

Westpac Banking Corp's BMY Position: Q1 2026 in Review

Westpac Banking Corp reduced its Bristol-Myers Squibb (BMY) stake by 4.5% in Q1 2026, selling an estimated $535K and leaving 192,545 shares worth $11.7M. The position accounts for 0.81% of the portfolio, ranked #18.

Westpac Banking Corp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.6M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Westpac Banking Corp held 192,545 shares of Bristol-Myers Squibb worth $11.7M as of Q1 2026.
  • Westpac Banking Corp sold 9,170 Bristol-Myers Squibb shares in Q1 2026, an estimated $535K.
  • Bristol-Myers Squibb made up 0.81% of Westpac Banking Corp's portfolio in Q1 2026, its #18 holding.
  • Westpac Banking Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Bristol-Myers Squibb position peaked at $30.6M in Q4 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.